Pfizer Inc (PFE) Announces Positive Results from BREAKWATER Trial

​Pfizer Inc. (NYSE:PFE) is among the Best Affordable Stocks Under $40 to Buy. On February 17, Pfizer Inc. (NYSE:PFE) announced positive results from its key BREAKWATER trial, which is testing BRAFTOVI in combination with cetuximab and FOLFIRI in patients with metastatic colorectal cancer. Management noted that the combination showed significant PFS improvement and better overall survival. Although the overall survival was a secondary descriptive endpoint, without statistics, it showed clinically meaningfu ...